Haplo a couple of points regarding Patto:
1. The oldboard did include him - remember has been on several years now.
2. He likely had 100% control on handling the vaccine announcement - he should had a panel with Prof.Frazer presenting the results, and Q&A session with investors, i would bet impact would have been less on SP
3. I think he is the right man for leading the pharmaceutical part forward however he has very limited experience in medical device & general small companies coming from predominantly big pharma- I wouldmuch prefer a man of Seaburg's elk for this part and for me would be reduction of risk having a seasoned medical device player for these aspects going forward for success of the company It is different ball game to pharma and imo you can't blend the two.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-290
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.30 |
Change
-0.380(2.42%) |
Mkt cap ! $323.4M | |||
| Open | High | Low | Value | Volume |
| $15.70 | $15.94 | $15.02 | $290.0K | 18.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 280 | $15.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.57 | 779 | 1 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |